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Abstract: We report the first total synthesis of four possible absolute configurations and four other regional isomers of a naturally 
occurring alkaloid crotonine, which was isolated from Croton tiglium L. (Euphoriaceae) without elucidation of its absolute  
configuration. The concise five-step route with a chirally poor and regioselective strategy starting from monosaccharides was  
established, and the absolute structure of the natural crotonine was determined by comparison of the NMR spectra and optical  
rotations of the synthetic products. 
Keywords: total synthesis, crotonine, 2-(furan-2-yl)-5-(2,3,4-trihydroxy-butyl)-1,4-diazine, Croton tiglium L. (Euphoriaceae),  
analgesics
Introduction 
Pyrazines are important components of processed foods and 
are associated with the generation of flavor and color, such as 
those of fermented cacao, cheese and wines.1 The Maillard 
reaction of amino acids with reducing sugars has become the 
primary process for generating these pyrazine derivatives in 
food processing.2 Some molecules containing the pyrazine 
pharmacophore have exhibited remarkable pharmacological 
activities with antitumor,3 diuretic,4 immunomodulatory5  
and analgesic effects.6 Crotonine (2-(furan-2-yl)-5-(2,3,4-
trihydroxy-butyl)-1,4-diazine) was isolated from Croton  
tiglium L. (Euphoriaceae) without determination of the absolute
configuration. However, the analgesic properties were obvious 
compared to those of morphine.7 To determine the absolute 
structure of natural crotonine, a concise saccharide-based five-
step route was developed for the synthesis of all possible chiral
isomers. The synthesis of pyrazine derivatives has attracted 
much interest due to their numerous scientific applications in 
both chemistry and biology. The condensation reaction of  
diamines with diols,8 hydroxyketones9 and diketones10 under 
catalysis by a transitional metal or base are the main reaction 
types reported in the literature. In our case, inexpensive mono-
saccharides were adopted as the starting material and chirality 
source for the preparation of α-dicarbonyl intermediates.11 
Pyrazine condensation of the diamine and 3-deoxy-aldos-2-
uloses intermediates, which is the key step in the reaction  
sequence, was catalyzed by potassium hydroxide, and other 
reaction conditions were successively investigated. The retro-
synthetic analysis is outlined in Scheme 1. 
 
Results and Discussion 
The preparation of the 1,2-ethylenediamine intermediate 5 
was initiated with furfuraldehyde 1 (Scheme 2).12 Henry  
addition with nitromethane generated 2-(2-nitroethenyl)furan 2 
in 72% yield, which was followed by treatment with  
methoxylamine hydrochloride to yield N-methoxyethylamine 
3 in 88% yield. According to the published procedure,  
reduction of 3 by zinc powder and acetic acid was attempted to 
generate 1,2-ethylenediamine 5 directly, however, this reaction 
only yielded a series of partially reduced byproducts and was 
difficult for purification.12 While catalytic hydrogenation over 
Pd/C only afforded partially reduced monoamine at the nitro 
group, when the Pd/C-catalyzed reaction was conducted under 
higher pressure or temperature, or a more active reducing  
reagent such as palladium hydroxide was used, the reduction 
of 3 produced an over-reduced product at the furan moiety. An 
exchange strategy succeeded in cleaving the methoxyl group 
from the nitrogen to yield nitro-ethenamine 4 in 95% yield,13 
followed by reduction with LiAlH4 in THF to afford 1,2-
ethylenediamine intermediate 5 in 52% yield. 
Construction of the 3-deoxy-aldos-2-ulose intermediates 
8a–8d started with monosaccharides (Scheme 3), such as D-
glucose 6a, D-galactose 6b, L-sorbose 6c and L-glucose 6d, 
which possess different potential chiral centers at the 2" and 3" 
positions in the final product. Refer to the method described in 
the literature,11 the monosaccharides reacted with benzoyl 
hydrazine to yield 3-deoxy-bis(benzoylhydrazones) 7a–7d in 
63%–93% yield. The mechanism was explained as a repeated 
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intramolecular rearrangement and dehydration process of the 1 
and 2 position of the monosaccharide.11 After easily obtaining 
the products 7a–7d by filtration, a transhydrazonation reaction 
with benzaldehyde afforded 3-deoxy-aldos-2-uloses 8a–8d in 
25%–37% yield. 
The condensation of the two key intermediates (i.e., 5 and 
8a–8d) was exhibited in Scheme 4, the reaction of 5 and 8 
without base conducted under an argon atmosphere was  
unsuccessful,14 because the alkalinity of 5 was insufficient to 
spontaneously catalyze the cyclization. When the strong base 
as potassium tert-butoxide or potassium hydroxide was used 
under an argon and anhydrous conditions,15 a trace product 
was obtained, but the yield failed to increase even with a high 
temperature and long reaction time. Next, the reaction was 
attempted in an air atmosphere using potassium hydroxide at  
0 ºC, but no reaction occurred.16 Fortunately, the yield of 9 
was improved after increasing the temperature to room  
temperature, but the regional isomers 10 were also produced, 
the quantity of product 9 and 10 were in a 1:1 ratio (the ratio 
was determined by 1H NMR analysis). After we screened the 
reaction conditions, including varying the quantity of the  
reagents and the addition method, it was determined that the 
addition frequency of potassium hydroxide markedly influ-
enced the regioselectivity of the pyrazine condensation. In the 
synthesis of 9 and 10, room temperature and multiple additions 
of potassium hydroxide (i.e., 10 portions of solid for 1 hour) 
favored the generation of a higher ratio of para-substitution 9 
to meta-substitution 10 products (i.e., up to 5:1), and finally all 
8 regional and chiral isomers were synthesized and purified 
successively. 
A comparison of the spectroscopic data of the natural7 and 
synthetic products was conducted (Tables 1 and 2). The 1H 
NMR of 10a–10d differed from those of the natural product 
which exhibited a singlet peak for H-3 and H-5 of the pyrazine 
ring, indicating that 10a–10d were meta-substitution products; 
while 9a–9d and natural crotonine showed a doublet peak (J = 
1.1 to 1.4 Hz) which attributed them to the para-substitution 
products.17 The remaining 1H and 13C NMR data of 10a–10d 
were similar to that of 9a–9d, inferring that each pair of 9 and 
10 (i.e., 9a and 10a) were regional isomers and possessed the 
same chirality at 2" and 3" position which were controlled by 
the chirality of intermediates 8a–8d. To the para-substitution 
products 9a–9d, the characteristic proton signal of 1" of 9b 
and 9c crotonine showed only one set of doublet peak, that 
differed obviously from that of 9a, 9d and the natural  
crotonine which exhibited two set of dd peaks, in addition, the 
1H and 13C NMR data for 9a and 9d matched those of the  
reported natural product exactly, indicating that the absolute 
configuration of natural crotonine only could be equal to 9a or 
9d. A further comparison of the optical rotation of 9a and 9d 
indicated that that of 9a (2"S, 3"R)-crotonine ([α]24D   – 30.0 (c 
0.17, MeOH)) was closer to that of the natural product ([α]20D   – 
6.8 (c 0.25, MeOH)), because the enantiomer 9d (2"R, 3"S)-
crotonine ([α]25D   + 23.5 (c 0.18, MeOH)) produced an opposite 
optical rotation that was substantially different from that of the 
natural product. Therefore, we inferred that the most likely 
absolute configuration of crotonine was identical to 9a as  
2-(furan-2'-yl)-5-(2"S,3"R,4"-trihydroxy-butyl)-1,4-diazine. 
In conclusion, we devised a concise five-step saccharide-
based procedure to synthesize all eight possible regional and 
chiral isomers of crotonine for the first time. This method may 
be conveniently extended to other diamines and monosaccha-
rides for the synthesis of a series of potentially bioactive  
pyrazines. Then, we determined that the most probable  
absolute configurations of the natural product by comparison 
of the NMR spectra and optical rotation data. 
 
Experimental Section 
General Experimental Procedures. All reactions were 
performed with chemically pure solvents without further  
purifications unless otherwise noted. Dry solvent was obtained 
by a standard procedure. Dry tetrahydrofuran (THF) was  
distilled over a sodium-potassium alloy. Diethylformamide 
 









































Scheme 1.  Retrosynthetic analysis of crotonine 
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(DMF) was distilled over calcium hydride. Yields refer to 
chromatographically and spectroscopically homogeneous  
materials, unless otherwise noted. Reagents were used as  
received without further purification. Silica gel (200–300 
mesh, Qingdao Marine Chemical Ltd., China), and light petro-
leum ether (bp 60–90 ºC), ethyl acetate and methanol were 
used for product purification used for flash column chromatog-
raphy. Purity of compounds were determined by Agilent 1200 
Series HPLC using Thermo Hypersil Gold C18 column eluted 
with a mixture of methanol and water. NMR spectra were  
recorded in CDCl3, C5D5N and Methanol solutions on Bruker 
AV-400/800 and Bruker DRX-500 instrument with tetrame-
thylsilane (TMS) as an internal reference. IR spectra were 
recorded with KBr pellets on a Bruker Tensor 27 FT-IR spec-
trometer. UV data were obtained on a Shimadzu UV-2401A 
spectrophotometer. Highresolution mass spectral analysis 
(HRMS) data were recorded via electron impact mass  
spectrometry using a time of flight analyzer. Optical rotations 
were determined on a Jasco P-1020 digital polarimeter. 
 
2-(2-Nitroethenyl)furan (2). According to the literature 
procedure,12 to a 2 L three neck flask was added 1 (100 g, 1.04 
mol) and nitromethane (63.5 g, 1 equivalent) before 200 mL 
methanol was added at 0 ºC, an aqueous sodium hydroxide (44 
g, 1.1 equivalent) dissolved in 200 mL water was dropped into 
the mixture slowly to maintain the system stirring below 0 ºC, 
then maintain the mixture stirring for 1 hour at 0 ºC. Then 200 
mL ice-water was poured into the mixture to generate a brown 
solution. To a cold solution prepared by 300 mL concentrated 
hydrochloride and 300 mL water, the former brown solution 
was added in slowly to furnish a yellow solid. Filtrated and 
washed by water several times, afforded the crude product, 
after repeated crystallization with methanol affording 2 as a 
yellow needle crystal 103 g (72%). 1H NMR (400 MHz, 
CDCl3) δ ppm: 7.74 (d, J = 13.2 Hz, 1H), 7.56 (dd, J = 1.2, 0.5 
Hz, 1H), 7.47 (d, J = 13.2 Hz, 1H), 6.88 (d, J = 3.5 Hz, 1H), 
6.55 (dd, J = 3.5, 1.8 Hz, 1H). 
 
1-(Furan-2-yl)-2-nitro-N-methoxyethylamine (3). To a 
mixture of 2 (102 g, 0.73 mol), methoxylamine hydroxy-
chloride (74 g, 1.2 equivalent) and sodium bicarbonate (74 g, 
1.2 equivalent) was dissolved with 150 mL water and stirred, 
at the end of carbon dioxide generation, 650 mL THF was 
added and discharged the atmosphere with nitrogen for three 
times, stirred at room temperature overnight. When the reaction
was complete, seperated 3 times by 200 mL ethyl acetate before
combined the organic layer and concentrated the solvent, 
filtrated and affordded a yellow liquid 92 g (88%). 1H NMR 
(400 MHz, CDCl3) δ ppm: 7.37 (m, 1H), 6.34 (m, 1H), 6.31 (d, 
J = 2.5 Hz, 1H), 5.74 (br. s, 1H), 4.96–4.75 (m, 2H), 4.69 (dd, 
J = 11.9, 4.2 Hz, 1H), 3.46 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ ppm: 148.9, 142.6, 110.4, 108.4, 74.5, 62.4, 56.3. 
 
1-(Furan-2-yl)-2-nitro-ethenamine (4). Added a solution 
of 3 in 50 mL dry DMF (22 g, 118.3 mmol) slowly to t-BuOK 
(29.2 g, 2.2 equivalent) dissolved in 200 mL anhydrous THF, 
maitaning the temperature at – 10ºC, then keep stirring for 5 h 
at room temprature, seperated by ethyl acetate and water for 5 
times, combined the organic layer and concentrated the solvent 
after dried over with sodium sulfate, and the crude product 
was purified by recrystallization with methanol, dried under 
air to generate 4 as a brown solid 17.3 g (95%). 1H NMR (400 
MHz, CDCl3) δ ppm: 7.64 (d, J = 1.1 Hz, 1H), 7.08 (s, 1H), 
6.96 (d, J = 3.6 Hz, 1H), 6.59 (dd, J = 3.6, 1.7 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ ppm: 145.9, 145.1, 113.0, 112.8, 
108.4; ESIMS: 155 [M + H]+, 177 [M + Na]+. 
 
1-(Furan-2-yl)-1,2-ethylenediamine (5). To a solution of 
LiAlH4 in 200 mL dry THF was dropped in a solution of 4 in 
50 mL THF at a liquid nitrogen-acetone bath maintaining the 
temprature below – 10 ºC, the reaction finished after 5 hours at 
0 ºC, quenched with water very carefully, filtrated and affored 
a yellow solution, purified by RP-18 column and gave 5 as a 
brown liquid 11.2 g (90 mmol, 52%), conserved at – 20 ºC 
under nitrogen. 1H NMR (400 MHz, CDCl3) δ ppm: 7.35 (m, 
1H), 6.28 (m, 1H), 6.17 (m, 1H), 3.95 (m, 1H), 3.04 (dd, J = 
12.5, 4.2 Hz, 1H), 2.93 (dd, J = 7.7, 3.8 Hz, 1H), 2.14 (br. s, 
4H); 13C NMR (100 MHz, CDCl3): δ ppm: 157.0, 141.7, 110.1, 
105.1, 51.7, 46.7; HRMSEI m/z: calcd for C6H10N2O [M]+: 
126.0793, found: 126.0796. 
 
3-Deoxy-D-erythro-hexos-2-ulose bis(benzoylhydrazone) 
(7a). Followed the methods of Khadem,11e to a solution of 600 
mL ethanol and 120 mL water was added D-glucose 6a (30 g, 
0.17 mmol), benzoylhydrazine (46 g, 0.34 mmol) and p-
p-Toluidine, Benzoylhydrazine
8a-8d
Acetic acid, Ethanol/H2O, reflux

























































Scheme 3.  Synthesis of intermediates 8a–8d 
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toluidine (12 g, 0.11 mmol) followed by 50 mL acetic acid, 
refluxed for 7 hours. Filtrated afforded a white solid, washed 
by water and ethanol, then a crystallization with ethanol 
generated 7a as a white needle 44.6 g (0.12 mmol, 71%). [α]24D   
+ 4.8 (c 0.56, Pyridine); 1H NMR (400 MHz, C5D5N) δ ppm: 
14.61 (s, 1H), 14.33 (s, 1H), 10.41 (s, 1H), 9.71 (m, 4H), 
9.00–8.82 (m, 6H), 6.24 (br. s, 1H), 5.98–5.66 (m, 3H), 5.14 
(br. s, 2H); 13C NMR (100 MHz, C5D5N) δ ppm: 167.3, 166.5, 
158.2, 151.1, 136.1, 135.8, 134.3, 131.0, 130.8, 130.5, 130.2, 
77.0, 75.1, 66.3, 32.6; HRMSEI m/z: calcd for C20H22N4O5 
[M]+: 398.1590, found 398.1568. 
 
3-Deoxy-D-threo-hexos-2-ulose bis(benzoylhydrazone) 
(7b). The procedure was conducted as the synthsis of 7a,  
D-galactose 6b 10 g, benzoylhydrazine 15.4 and p-toluidine 4 
g, generated 7b as a white needle 15.57 g (80%). [α]24D   + 47.0 
(c 0.42, Pyridine); 1H NMR (400 MHz, C5D5N) δ ppm: 14.48 
(s, 1H), 14.35 (s, 1H), 10.30 (s, 1H), 9.81 (br. d, J = 7.1 Hz, 
2H), 9.69 (br. d, J = 7.7 Hz, 2H), 8.89 (m, 6H), 6.33 (br. s, 
1H), 5.96–5.66 (m, 3H), 5.31–5.01 (m, 2H); 13C NMR (100 
MHz, C5D5N) δ ppm: 167.1, 166.1, 157.6, 150.7, 136.3, 134.1, 
130.9, 130.7, 130.4, 130.2, 77.2, 73.6, 66.4, 33.4; HRMSEI 
m/z: calcd for C20H22N4O5 [M]+: 398.1590, found 398.1601. 
 
3-Deoxy-L-threo-hexos-2-ulose bis(benzoylhydrazone) 
(7c). The procedure was conducted as the synthsis of 7a,  
L-sorbose 6c 10 g, benzoylhydrazine 15.4 g and p-toluidine 4 
g, generated 7c as a white needle 18.5 g (93%). [α]24D   – 51.2 (c 
0.54, Pyridine); 1H NMR (400 MHz, C5D5N) δ ppm: 14.48 (s, 
1H), 14.35 (s, 1H), 10.31 (s, 1H), 9.81 (br. d, J = 7.1 Hz, 2H), 
9.69 (br. d, J = 7.7 Hz, 2H), 8.89 (m, 6H), 6.33 (br. s, 1H), 
5.87 (m, 2H), 5.72 (m, 1H), 5.36–5.09 (m, 2H); 13C NMR (100 
MHz, C5D5N) δ ppm: 167.1, 166.3, 157.6, 150.7, 136.3, 134.1, 
130.9, 130.8, 130.4, 130.2, 77.2, 73.6, 66.4, 33.4; HRMSEI 
m/z: calcd for C20H22N4O5 [M]+: 398.1590, found 398.1592. 
 
3-Deoxy-L-erythro-hexos-2-ulose bis(benzoylhydrazone) 
(7d). The procedure was conducted as the synthsis of 7a, L-
glucose 6d 1 g, benzoylhydrazine 1.54 g and p-toluidine 0.4 g, 
generated 7d as a white needle 1.25 g (63%). [α]24D   – 3.4 (c 
0.45, Pyridine); 1H NMR (400 MHz, C5D5N) δ ppm: 14.60 (s, 
1H), 14.27 (s, 1H), 10.27 (s, 1H), 9.70 (br. d, J = 7.1 Hz, 2H), 
9.62 (br. d, J = 7.4 Hz, 2H), 8.92–8.84 (m, 2H), 8.80 (m, 4H), 
6.20 (br. s, 1H), 5.93–5.61 (m, 3H), 5.07 (br. s, 2H); 13C NMR 
(100 MHz, C5D5N) δ ppm: 167.2, 166.2, 157.8, 151.0, 136.1, 
135.7, 134.3, 130.9, 130.7, 130.3, 130.0, 76.8, 75.0, 66.2, 32.4; 
HRMSEI m/z: calcd for C20H22N4O5 [M]+: 398.1590, found 
398.1588. 
 
3-Deoxy-D-erythro-hexos-2-ulose (8a). Followed the 
methods of Khadem,11d to 300 mL methanol was added 7a (20 
g, 54 mmol) and 500 mL water, after acetic acid (12 mL) and 
benzaldehyde (32 mL) were added in, the mixture was to 
refluxed for 2 hours, when the hydrazone was completely 
dissovled, the reaction was contiued to refluxed for another 10 
hours with vigrously. Filtrated and the solution was 
concentrated in vaccour, the residue was seperated with water 
and dichloromethane by 5 times, combined the aqueous part 
and evaperated the solvent, furnished 8a as a yellow colloidal 
solid 3.2 g (32 mmol, 37%); 1H NMR (400 MHz, CD3OD)  δ 4.42 (br. s, 1H), 4.39 (br. s, 1H), 4.37 (br. s, 1H), 4.30 (br. s, 
1H), 4.28 (br. s, 1H), 4.24 (d, J = 2.7 Hz, 1H), 4.18 (m, 1H), 
4.05 (m, 1H), 4.00 (m, 1H), 3.97 (m, 1H), 3.90 (d, J = 2.8 Hz, 
 
Scheme 4.  Synthesis of 9 and 10 
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1H), 3.86 (m, 1H), 3.80 (m, 1H), 3.69 (m, 4H), 3.65 (m, 2H), 
3.61 (m, 2H), 3.57 (m, 1H), 3.53 (m, 1H), 3.42 (dd, J = 3.9, 
1.7 Hz, 2H), 3.30 (dd, J = 5.5, 3.9 Hz, 1H), 2.45 (m, 1H), 2.16 
(m, 3H), 1.99 (m, 1H), 1.85 (m, 2H), 1.76 (m, 2H); 13C NMR 
(100 MHz, CD3OD) δ 172.4, 172.0, 170.9, 169.7, 106.8, 106.7, 
106.5, 106.2, 100.7, 100.1, 100.0, 99.9, 98.4, 98.3, 93.7, 93.3, 
88.4, 88.3, 87.3, 87.2, 74.3, 74.0, 73.7, 73.6, 72.5, 72.2, 72.1, 
72.0, 69.2, 68.8, 67.8,66.6, 65.3, 65.2, 65.1, 65.0, 63.9, 63.8, 
63.2, 62.9, 62.8, 62.8, 60.3, 60.3, 55.7, 55.7, 55.7, 55.6, 42.89, 
42.4, 42.1, 41.9, 38.6, 34.2, 33.0, 32.6. [α]24D   + 11.0 (c 0.38, 
H2O); HRMSEI m/z: calcd for C6H10O5 [M]+: 162.0528, found: 
162.0534. 
 
3-Deoxy-D-threo-hexos-2-ulose (8b). The procedure was 
conducted as the synthsis of 8a. 7b 15.57 g, acetic acid (18.7 
mL) and benzaldehyde (25 mL), afforded a yellow colloidal 
solid 1.96 g (25%); 1H NMR (400 MHz, CD3OD) δ 4.44 (m, 
1H), 4.41 (br. s, 0.5H), 4.39 (br. s, 0.5H), 4.34 (m, 0.5H), 4.32 
(br. s, 1H), 4.30 (br. s, 1H), 4.26 (m, 0.5H), 4.19 (m, 1.5H), 
4.07 (m, 1.5H), 4.02 (d, J = 5.0 Hz, 1.5H), 4.00 (d, J = 1.2 Hz, 
1.5H), 3.88 (dd, J = 4.5, 2.8 Hz, 1H), 3.83 (d, J = 2.3 Hz, 
0.5H), 3.80 (m, 0.5H), 3.72 (m, 5H), 3.67 (m, 2.5H), 3.62 (m, 
1.5H), 3.59 (d, J = 5.0 Hz, 1.5H), 2.46 (dt, J = 13.7, 7.5 Hz, 
1H), 2.17 (m, 3H), 2.02 (m, 0.6H), 1.82 (m, 4H); 13C NMR 
(150 MHz, CD3OD) δ 172.4, 172.2, 171.7, 171.3, 105.5, 105.4, 
105.2, 105.0, 99.5, 99.4, 98.8, 98.8, 98.7, 87.2, 86.0, 85.9, 
71.3, 71.0, 70.8, 70.7, 68.0, 65.4, 63.9, 63.9, 62.6, 62.6, 61.9, 
61.5, 41.6, 41.2, 40.9, 40.7, 37.4, 33.0, 31.8, 31.3; [α]24D   – 19.8 
(c 0.41, H2O); HRMSEI m/z: calcd for C6H10O5 [M]+: 
162.0528, found: 162.0531. 
 
3-Deoxy-L-threo-hexos-2-ulose (8c). The procedure was 
conducted as the synthsis of 8a. 7c 8.54 g, acetic acid 10.3 mL 
and benzaldehyde 13.7 mL, afforded 8c as a yellow colloidal 
solid 1.07 g (31%); 1H NMR (400 MHz, CD3OD) δ 4.44 (br. s, 
1H), 4.41 (br. s, 0.5H), 4.39 (s, 0.5H), 4.30 (m, 1H), 4.32 (d, J 
= 4.5 Hz, 1H), 4.29 (d, J = 4.5 Hz, 1H), 4.27 (d, J = 2.6 Hz, 
1H), 4.19 (m, 0.5H), 4.06 (m, 1H), 4.02 (d, J = 5.3 Hz, 1H), 
4.00 (m, 1H), 3.88 (m, 1H), 3.83 (dd, J = 5.0, 2.7 Hz, 1H), 
3.80 (m, 1.5H), 3.70 (m, 3.5H), 3.63 (m, 2H), 3.56 (m, 2.5H), 
2.46 (m, 1H), 2.15 (m, 2H), 2.02 (m, 0.5H), 1.81 (m, 4H); 13C 
NMR (100MHz, CD3OD) δ 170.1, 170.0, 169.6, 169.3, 105.5, 
105.4, 105.2, 105.0, 99.5, 99.5, 98.8, 98.8, 98.7, 87.2, 87.0, 
86.0, 85.9, 71.3, 71.0, 70.8, 67.9, 65.4, 65.3, 64.0, 63.9, 62.6, 
62.6, 61.9, 61.6, 41.6, 41.2, 40.9, 40.7, 35.2, 33.0, 31.8, 31.4; 
[α]24D   + 12.2 (c 0.55, H2O); HRMSEI m/z: calcd for C6H10O5 
[M]+: 162.0528, found: 162.0537. 
 
3-Deoxy-L-erythro-hexos-2-ulose (8d). The procedure was 
conducted as the synthsis of 8a. 7d 1.15 g, acetic acid 1.38 mL 
and benzaldehyde 1.85 mL, afforded 8d as a yellow colloidal 
solid 104 mg (23%); 1H NMR (400 MHz, CD3OD) δ 4.44 (m, 
1H), 4.41 (d, J = 3.1 Hz, 0.5H), 4.39 (m, 0.5H), 4.32 (br. s, 
1H), 4.30 (br. s, 1H), 4.20 (m, 1H), 4.08 (dt, J = 9.4, 4.2 Hz, 
1.5H), 4.02 (dd, J = 6.5, 3.7 Hz, 2H), 4.00 (d, J = 4.5 Hz, 2H), 
3.89 (m, 1H), 3.72 (m, 5H), 3.68 (m, 3H), 3.62 (m, 3H), 2.45 
(m, 1H), 2.18 (m, 2.5H), 1.84 (m, 5H); 13C NMR (100 MHz, 
CD3OD) δ 171.2, 170.4, 170.2, 169.8, 105.6, 105.4, 105.3, 
105.0, 99.5, 99.5, 98.9, 98.8, 98.7, 87.1, 87.0,  86.0, 85.9, 71.3, 
70.9, 71.0 , 67.9, 65.4, 65.4, 63.9, 62.7, 62.6, 61.6 54.5, 54.5, 
54.4, 41.6, 41.2, 40.9, 40.7, 33.1, 31.8, 31.4; [α]24D   – 10.2 (c 
0.62, H2O); HRMSEI m/z: calcd for C6H10O5 [M]+: 162.0528, 
found: 162.0529. 
 
Synthesis of 9 and 10. To 1.5 equivalent 8 dissolved in 
ethaol was added 1.0 equivalent 5 in ethanol, allowed the 
mixture to stirred for 30 miniuts before pattasium hydroxide 
(3.0 equivalent) was added in 10 portions for 1 hour at room 
temperature, and kept reaction for a further 5 hours. Quanched 
by saturated ammonium chloride aqueous solution and 
evaporated the ethanol, after 20 mL water was added, 
extracted the low polarity impurities with dichloromethane for 
one time, the aquous phase was extrated with n-bultyl alchohol 
for 5 times, combined the organic phase and concentrated 
under vaccuum, seperated the product by silica gel column and 
obtained the mixed 9 and 10 isomers, after seperating by 
repeated Preparative Thin-Layer Chromatography with an 
Table 1. 1H NMR data of natural crotonine and synthetic products in CD3OD 
Pos. crotonine1 9a1 9b2 9c2 9d2 10a2 10b2 10c2 10d2
2          
3 8.88 (d, 1.4) 8.82 (d, 1.4) 8.90 (d, 1.1) 8.92 (d, 1.1) 8.90 (d, 1.4) 8.79 (s) 8.78 (s, 1H) 8.78 (s, 1H) 8.79 (s, 1H) 
5      8.39 (s) 8.39 (s, 1H) 8.39 (s, 1H) 8.38 (s, 1H) 
6 8.49 (d, 1.4) 8.45(d, 1.4) 8.51 (d, 1.1) 8.53 (d, 1.1) 8.50 (d, 1.4)     
3' 7.15 (dd, 0.6, 
3.4) 
7.11 (d, 3.4) 7.18 (d, 2.9) 7.20 (d, 3.0) 7.17 (d, 3.4) 7.25 (d, 3.4) 7.23 (d, 3.3) 7.23 (d, 3.3) 7.24 (d, 3.4) 
4' 6.61 (dd, 1.7, 
3.4) 
6.57 (dd, 3.4, 
1.7) 




6.63 (dd, 3.4, 
1.7) 
6.65 (dd, 3.3, 
1.7) 
6.63 (dd, 3.3, 
1.7) 
6.64 (dd, 3.3, 
1.7) 
6.64 (dd, 3.3, 
1.7) 
5' 7.69 (dd, 0.6, 
1.7) 
7.66 (dd, 1.7, 
0.6) 
7.72 (br. d, 
0.9) 
7.73 (br. d, 
0.9) 
7.71 (d, 1.7) 7.74 (br. d, 
0.9) 
7.72 (br. s) 7.72 (br. s) 7.74 (br. d, 
0.9) 




















2" 3.95 (m) 3.95 (m, 2H) 4.09 (m) 4.10 (m) 3.97 (m) 4.04 (m) 4.14 (td, 6.7, 
3.0) 
4.13 (m) 4.03 (m) 
3" 3.56 (m) 3.53 (m) 3.58 (m) 3.59 (m) 3.56 (m) 3.60 (m) 3.60 (td, 5.9, 
3.2) 
3.60 (m) 3.61 (m) 




































1Recorded at 400 MHz; 2Recorded at 800 MHz; δ (ppm) and J in Hz. 
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eluent (ethyl acetate/methanol/aqueous ammonia = 98:2:5) and 
affordded the final sturcture 9 and 10 successively. 
 
Synthesis of 9a and 10a. 500 mg 5, 964 mg 8a and 666 mg 
pattasium hydroxide followed the general procedure A and 
afforded 261 mg yellow solid (26%), took out 60 mg and 
seperated by PTLC, obtained 9a (11.5 mg) and 10a (14 mg) as 
yellow solid successively. 
 
2-(Furan-2'-yl)-5-(2"S,3"R,4"-trihydroxy-butyl)-1,4-
diazine (9a). 1H and 13C NMR see Tables 1 and 2; [α]24D   – 30.0 
(c 0.17, MeOH); UV (MeOH) λmax(log ε): 272 (4.17) nm; IR 
(KBr) νmax cm–1: 3424, 2925, 1630, 1498, 1033, 884, 745, 591; 
1H and 13C NMR data, see Tables 1 and 2; HREIMS m/z: calcd 
for C12H14N2O4 [M]+: 250.0954, found: 250.0951. 
 
2-(Furan-2'-yl)-6-(2"S,3"R,4"-trihydroxy-butyl)-1,4-
diazine (10a). 1H and 13C NMR see Tables 1 and 2; [α]25D   – 
60.3 (c 0.09, MeOH); UV (MeOH) λmax(log ε): 328 (4.15) nm; 
IR (KBr) νmax cm–1: 3406, 2923, 2884, 1630, 1608, 1531, 1491, 
1154, 1068, 884, 749, 593; 1H and 13C NMR data, see Tables 1 
and 2; HREIMS m/z: calcd for C12H14N2O4 [M]+: 250.0954, 
found: 250.0961. 
 
Synthesis of 9b and 10b. 50 mg 5, 95 mg 8b and 66 mg 
pattasium hydroxide followed the general procedure and 
afforded 23 mg yellow solid (25%), seperated by PTLC and 




diazine (9b). 1H and 13C NMR see Table 1 and Table 2; [α]24D   
+ 58.7 (c 0.07, MeOH); UV (MeOH) λmax(log ε): 272 (4.14) 
nm; IR (KBr) νmax cm–1: 3421, 2925, 1631, 1501, 1384, 1113, 
1077, 1037, 746, 593; 1H and 13C NMR data, see Tables 1 and 




diazine (10b). 1H and 13C NMR see Tables 1 and 2; [α]25D   + 
44.1 (c 0.15, MeOH); UV (MeOH) λmax(log ε): 328 (4.70) nm; 
IR (KBr) νmax cm–1: 3421, 2956, 2927, 1630, 1605, 1529, 1491, 
1408, 1153, 1091, 1039, 1018, 752; 1H and 13C NMR data, see 
Tables 1 and 2; HREIMS m/z: calcd for C12H14N2O4 [M]+: 
250.0954, found: 250.0950. 
 
Synthesis of 9c and 10c. 50 mg 5, 95 mg 8c and 66 mg 
pattasium hydroxide followed the general procedure and 
afforded a 19 mg yellow solid (20%), seperated by PTLC and 




diazine (9c). 1H and 13C NMR see Tables 1 and 2; [α]25D   – 50.4 
(c 0.18, MeOH); UV (MeOH) λmax(log ε): 273 (4.03) nm; IR 
(KBr) νmax cm–1: 3423, 2928, 1630, 1604, 1501, 1111, 1059, 
1033, 751, 593; 1H and 13C NMR data, see Tables 1 and 2; 




diazine (10c). 1H and 13C NMR see Tables 1 and 2; [α]24D   – 
36.9 (c 0.12, MeOH); UV (MeOH) λmax(log ε): 328 (3.96) nm 
IR (KBr) νmax cm–1: 3423, 2927, 1630, 1529, 1491, 1153, 1091, 
1039, 1018, 752, 595; 1H and 13C NMR data, see Tables 1 and 
2; HREIMS m/z: calcd for C12H14N2O4 [M]+: 250.0954, found: 
250.0958. 
 
Synthesis of 9d and 10d. 30 mg 5, 58 mg 8d and 40 mg 
pattasium hydroxide followed the general procedure and 
afforded 13 mg yellow solid (22%), seperated by PTLC and 




diazine (9d). 1H and 13C NMR see Tables 1 and 2; [α]25D   + 23.5 
(c 0.18, MeOH); UV (MeOH) λmax(log ε): 272 (4.27) nm; IR 
(KBr) νmax cm–1: 3423, 2926, 1630, 1498, 1135, 1109, 1033, 
746, 591; 1H and 13C NMR data, see Tables 1 and 2; HREIMS 
m/z: calcd for C12H14N2O4 [M]+: 250.0954, found: 250.0948. 
 
2-(Furan-2'-yl)-6-(2"R,3"S,4"-trihydroxy-butyl)-1,4-
diazine (10d). 1H and 13C NMR see Tables 1 and 2; [α]25D   + 
65.3 (c 0.24, MeOH); UV (MeOH) λmax(log ε): 328 (3.95) nm; 
IR (KBr) νmax cm–1: 3417, 2922, 2883, 1631, 1531, 1491, 1409, 
1154, 1068, 1038, 1015, 884, 749, 593; 1H and 13C NMR data,
 
Table 2. 13C NMR data of crotonine and synthetic products in CD3OD 
Position crotonine 9a1 9b2 9c2 9d2 10a2 10b2 10c2 10d2
2 143.9 143.8 144.0 143.9 144.0 145.6 145.7 145.9 145.6
3 140.1 140.1 140.2 140.1 140.1 138.2 138.2 138.4 138.1 
5 154.8 154.7 154.6 154.5 154.8 144.1 144.0 144.2 144.1 
6 145.7 145.7 145.9 145.8 145.8 156.7 156.5 156.7 156.7 
2' 152.3 152.2 152.4 152.3 152.4 152.5 152.5 152.7 152.5 
3' 111.2 111.3 111.4 111.2 111.3 111.9 111.9 112.1 111.9 
4' 113.3 113.3 113.4 113.2 113.3 113.4 113.4 113.6 113.4 
5' 145.9 145.9 145.8 145.7 146.0 146.0 146.0 146.2 146.0 
1" 39.6 39.6 40.0 39.9 39.7 39.8 40.2 40.4 39.8 
2" 72.9 72.9 72.2 72.1 73.0 72.9 72.1 72.3 73.0 
3" 76.1 76.1 75.1 75.1 76.2 76.2 75.2 75.4 76.2 
4" 64.6 64.5 64.4 64.3 64.6 64.6 64.4 64.6 64.6
1Recorded at 400 MHz; 2Recorded at 800 MHz; δ (ppm) and J in Hz. 
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see Tables 1 and 2; HREIMS m/z: calcd for C12H14N2O4 [M]+: 
250.0954, found: 250.0961. 
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